Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  Gianluigi Savarese

Gianluigi Savarese

Associate Professor of Cardiology

Karolinska Institute, Stockholm, SE

Biography

Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden. 

Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology. 

Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018. 

Prof Savarese has published over 150 publications in peer-reviewed journals, focusing mainly on heart failure, epidemiology and cardiovascular pharmacotherapy. 

Prof Gianluigi Savarese is Section Editor of European Cardiology Review.

Featured Courses

Bridging the Gap in Worsening Heart Failure: Evidence-Based Approaches to Optimising Treatment Outcomes
  • 1.25 AMA PRA Credit

Learning objectives

  • To identify high-risk patient features indicative of worsening Heart Failure (HF)
  • Name validated tools for serial prognostic assessment and risk stratification
  • Adopt the use of appropriate assessment tools during patient follow-up
  • Recall rates of recurrent HF events and their associated healthcare costs in worsening HF patients
  • Recall the clinical benefit of emerging treatments targeted to treating worsening HF
  • Initiate available treatment for the tailored management of worsening HF
See more